The overall goal of this study is to evaluate the safety and exploratory efficacy of the injectable filler agent composed of umbilical cord mesenchymal stem cells and hyaluronic acid for the improvement of wrinkles, acne, pitting scar and so on.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
30
Proportion of patients with non-serious and serious adverse events
Time frame: Change from baseline up to week 12 after injection.
Wrinkle Severity Rating Scale (WSRS) Evaluation
An improvement was judged by the outcome of the preoperative grade minus the postoperative grade in accordance with the Wrinkle Severity Rating Scale (WSRS).The severity was measured using the Wrinkle Severity Rating Scale (WSRS), where 0 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Extreme, which is an ordinal scale.
Time frame: Change from baseline at week 2, 6 and 12.
Global Aesthetic Improvement Scale (GAIS) Evaluation
An improvement was judged by the outcome of the preoperative grade minus the postoperative grade in accordance with the Global Aesthetic Improvement Scale (GAIS).
Time frame: Change from baseline at week 2, 6 and 12.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.